Daniela Campos-Vilasboas
Braga, 4710057, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Differential effects of lifespan-extending genetic manipulations in an animal model of MJD/SCA3.
Journal: Mechanisms of ageing and development
Published: February 27, 2025
Allosteric Modulation of Pathological Ataxin-3 Aggregation: A Path to Spinocerebellar Ataxia Type-3 Therapies.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 05, 2025
Allosteric Modulation of Pathological Ataxin-3 Aggregation: A Path to Spinocerebellar Ataxia Type-3 Therapies.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
Therapeutic Effects of Hemerocallis citrina Baroni Extract on Animal Models of Neurodegenerative Diseases Through Serotonin and HLH-30/TFEB-Dependent Mechanisms.
Journal: International journal of molecular sciences
Published: January 15, 2025
Differential impact of diesel exhaust particles on glutamatergic and dopaminergic neurons in Caenorhabditis elegans: A neurodegenerative perspective.
Journal: Environment international
Published: December 29, 2023
Learning the Biochemical Basis of Axonal Guidance: Using Caenorhabditis elegans as a Model.
Journal: Biomedicines
Published: June 01, 2023
Drug repurposing of dopaminergic drugs to inhibit ataxin-3 aggregation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 24, 2023
Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3.
Journal: The Journal of clinical investigation
Published: May 31, 2022
Aripiprazole Offsets Mutant ATXN3-Induced Motor Dysfunction by Targeting Dopamine D2 and Serotonin 1A and 2A Receptors in C. elegans.
Journal: Biomedicines
Published: December 31, 2021
Novel Machado-Joseph disease-modifying genes and pathways identified by whole-exome sequencing.
Journal: Neurobiology of disease
Published: July 30, 2021
Data on the effects of Hyptis spp. and Lycium spp. plant extracts in C. elegans models of genetically determined neurodegenerative diseases.
Journal: Data in brief
Published: October 30, 2020
Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease.
Journal: Neurobiology of disease
Published: October 27, 2020
Last Updated: 09/26/2026